@FiercePharma: Forest fights back against Icahn in filing. Article | Follow @FiercePharma
> Novartis has started construction of its new St. Petersburg manufacturing plant, the centrepiece of its planned, $500 million five-year investment into Russia. Article
> Lupin may find it tough to improve its operating margin this fiscal year, but the Indian generics maker's profitability is expected to jump in a couple of years, helped mainly by the launch of several lucrative products in the U.S. Item
> European regulators have followed FDA in granting marketing authorization for Bristol-Myers Squibb's Nulojix, which aims to prevent kidney transplant patients rejecting their new organ. Report
> Eli Lilly and Amylin Pharmaceuticals may put their disagreements over marketing pacts to one side temporarily after European regulators gave the thumbs-up to their once-weekly diabetes drug Bydureon. Story
> A recent meeting with Pfizer managers has confirmed optimism that the drugmaker will not be abandoning Groton, CT, completely, chamber officials said. News
> Sun Pharma won the FDA nod for its generic version of GlaxoSmithKline's migraine drug Imitrex. Item
Biotech News
@FierceBiotech: Abbott inks $470M pact for Biotest's Ph2 RA antibody program. Story | Follow @FierceBiotech
@JohnCFierce: This Tesaro deal reminds me of the success Clovis has had in raising big $$$. Experience+clear strategy in cancer is appealing to investors. | Follow @JohnCFierce
> FDA's safety concerns force Merck KGaA to kill cladribine MS program. Report
> FDA experts reject Novartis gout drug. Story
Drug Delivery News
> FDA looking for advice on regulating nanotech. Story
> Europe's Bydureon approval is victory for Alkermes. Report
> J&J drops Cypher drug-coated stents in more bad news for SurModics. Piece
> Body's blood-clotting machinery harnessed against cancer. Item
> Neural probe to include microchannels to deliver drugs to tinnitus sufferers. Article
> NIST to test the value of gold in drug-delivering nanoparticles. Article
Medical Device News
> Medtronic faces Senate scrutiny over Infuse. Article
> 3M accuses Porton CEO of blackmail. News
> GAO: FDA doesn't oversee device recalls properly. Article
> AZ, Dentsply reach deal on Astra Tech. Story
> Mauna Kea looks to raise $67.7M in IPO. Report
> Mendor raises $11.7M in Series B. Item
And Finally... To build up its medical device business in rural parts of India and China, Johnson & Johnson is focusing heavily on a strategy that involves simplifying things. Report